BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 29407769)

  • 21. Anticancer Mechanism of Flavonoids on High-Grade Adult-Type Diffuse Gliomas.
    Wong SC; Kamarudin MNA; Naidu R
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Epigallocatechin-3-Gallate on Matrix Metalloproteinases in Terms of Its Anticancer Activity.
    Tanabe H; Suzuki T; Ohishi T; Isemura M; Nakamura Y; Unno K
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MT1-MMP Cooperates with TGF-β Receptor-Mediated Signaling to Trigger SNAIL and Induce Epithelial-to-Mesenchymal-like Transition in U87 Glioblastoma Cells.
    Djediai S; Gonzalez Suarez N; El Cheikh-Hussein L; Rodriguez Torres S; Gresseau L; Dhayne S; Joly-Lopez Z; Annabi B
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational Methods for Structure-to-Function Analysis of Diet-Derived Catechins-Mediated Targeting of In Vitro Vasculogenic Mimicry.
    Uthamacumaran A; Suarez NG; Baniré Diallo A; Annabi B
    Cancer Inform; 2021; 20():11769351211009229. PubMed ID: 33953534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effect of Nano-Epigallocatechin-Gallate on Oxidative Stress and Matrix Metalloproteinases in Experimental Diabetes Mellitus.
    Bulboaca AE; Boarescu PM; Porfire AS; Dogaru G; Barbalata C; Valeanu M; Munteanu C; Râjnoveanu RM; Nicula CA; Stanescu IC
    Antioxidants (Basel); 2020 Feb; 9(2):. PubMed ID: 32093214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flavonoids: Broad Spectrum Agents on Chronic Inflammation.
    Lim H; Heo MY; Kim HP
    Biomol Ther (Seoul); 2019 May; 27(3):241-253. PubMed ID: 31006180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multifunctional effects of green tea catechins on prevention of the metabolic syndrome.
    Ikeda I
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():273-4. PubMed ID: 18296354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells.
    Annabi B; Lachambre MP; Bousquet-Gagnon N; Page M; Gingras D; Beliveau R
    Biochim Biophys Acta; 2002 Jan; 1542(1-3):209-20. PubMed ID: 11853893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of pro-/active MMP-2 by green tea catechins and prediction of their interaction by molecular docking studies.
    Chowdhury A; Nandy SK; Sarkar J; Chakraborti T; Chakraborti S
    Mol Cell Biochem; 2017 Mar; 427(1-2):111-122. PubMed ID: 28013477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinase inhibition by green tea catechins.
    Demeule M; Brossard M; Pagé M; Gingras D; Béliveau R
    Biochim Biophys Acta; 2000 Mar; 1478(1):51-60. PubMed ID: 10719174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigallocatechin gallate targeting of membrane type 1 matrix metalloproteinase-mediated Src and Janus kinase/signal transducers and activators of transcription 3 signaling inhibits transcription of colony-stimulating factors 2 and 3 in mesenchymal stromal cells.
    Zgheib A; Lamy S; Annabi B
    J Biol Chem; 2013 May; 288(19):13378-86. PubMed ID: 23548906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concanavalin-A-induced autophagy biomarkers requires membrane type-1 matrix metalloproteinase intracellular signaling in glioblastoma cells.
    Pratt J; Roy R; Annabi B
    Glycobiology; 2012 Sep; 22(9):1245-55. PubMed ID: 22692046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biophysical evidence for differential gallated green tea catechins binding to membrane type-1 matrix metalloproteinase and its interactors.
    Djerir D; Iddir M; Bourgault S; Lamy S; Annabi B
    Biophys Chem; 2018 Mar; 234():34-41. PubMed ID: 29407769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory Effects of Eight Green Tea Catechins on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activities.
    Satoh T; Fujisawa H; Nakamura A; Takahashi N; Watanabe K
    J Pharm Pharm Sci; 2016; 19(2):188-97. PubMed ID: 27518169
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.